A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208)-Reference-Cited by-同舟云学术

A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208)

Published:2019-08 Issue:2 Volume:270 Page:230-237
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Kobayashi Shogo,Nagano Hiroaki,Tomokuni Akira,Gotoh Kunihito,Sakai Daisuke,Hatano Etsuro,Seo Satoru,Terajima Hiroaki,Uchida Yoichiro,Ajiki Tetsuo,Satake Hironaga,Kamei Keiko,Tohyama Taiji,Hirose Tetsuro,Ikai Iwao,Morita Satoshi,Ioka Tatsuya

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference36 articles.

1. Treatment of borderline cases for curative resection of biliary tract cancer;Kobayashi;J Surg Oncol,2011

2. Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan;Miyakawa;J Hepatobiliary Pancreat Surg,2009

3. Surgical resection of hilar cholangiocarcinoma. Analysis of survival and postoperative complications;Hasegawa;World J Surg,2007

4. Gastroenterological surgery in Japan: the past, the present and the future;Colvin;Ann Gastorenterological Surg,2017

5. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma;Takada;Cancer,2002

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

2. Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer;Cancer Management and Research;2024-07

3. Impact of Surgical Margin Status on Survival and Recurrence After Pancreaticoduodenectomy for Distal Cholangiocarcinoma: Is Microscopic Residual Tumor (R1) Associated with Higher Rates of Local Recurrence?;Annals of Surgical Oncology;2024-04-28

4. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202;European Journal of Surgical Oncology;2024-02

5. Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations;Hepatology;2024-01-24